Ramtin Agah
Chief Medical Officer, Director · RenovoRx, Inc.
- 2025
- Apr 8, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ramtin Agah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Voll - $20K in RNXT purchases and sales in the last 12 months
- Shaun Bagai - $9K in RNXT purchases and sales in the last 12 months
- Laurence Marton - RNXT
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ramtin Agah?
Ramtin Agah is a corporate insider, tracked as Chief Medical Officer, Director of RenovoRx, Inc. (RNXT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Ramtin Agah last file a Form 4?
The most recent primary Form 4 on record is dated 8 April 2026, one of 8 filings going back to 2025.
Has Ramtin Agah been buying or selling stock?
Recorded transactions: 7 open-market purchases ($56K) and 0 open-market sales across all tracked filings.
